Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Current perspective on antithrombin drugs.

John L McGregor¹

¹Inserm Unit 331, Faculty of Medicine, RTH Laénnec, University of Lyon 1, Lyon, France. mcgregor@tri-london.ac.uk

Pathophysiology of Haemostasis and Thrombosis

|June 18, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2010

Same author

Prevention of atherosclerosis in patients living with HIV.

Vascular health and risk management·2009

Same author

CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI.

Journal of biomedicine & biotechnology·2008

Same author

CD36 N-terminal cytoplasmic domain is not required for the internalization of oxidized low-density lipoprotein.

Bioscience reports·2008

Same author

Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low- density lipoproteins.

Arteriosclerosis, thrombosis, and vascular biology·2007

Same author

Expression of VE-Cadherin in Peritubular Endothelial Cells during Acute Rejection after Human Renal Transplantation.

Journal of biomedicine & biotechnology·2007

Same journal

Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.

Pathophysiology of haemostasis and thrombosis·2011

Same journal

The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.

Pathophysiology of haemostasis and thrombosis·2011

Same journal

Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients.

Pathophysiology of haemostasis and thrombosis·2011

Same journal

The effect of chronic cadmium toxicity on blood pressure and plasma viscosity.

Pathophysiology of haemostasis and thrombosis·2011

Same journal

Serum and saliva sialic acid in periodontitis patients with and without cardiovascular disease.

Pathophysiology of haemostasis and thrombosis·2011

Same journal

Plasma tissue factor levels and salivary tissue factor activities of periodontitis patients with and without cardiovascular disease.

Pathophysiology of haemostasis and thrombosis·2011

See all related articles

Thrombin plays a key role in inflammation and tissue repair. Inhibiting thrombin may significantly impact the development of crescentic glomerulonephritis, a severe kidney disease.

Area of Science:

Biochemistry
Nephrology
Immunology

Background:

Thrombin is a serine protease crucial for blood coagulation, thrombosis, inflammation, and wound repair.
Protease-activated receptors (PARs) mediate thrombin's effects, triggering proinflammatory mediator production upon activation.
PARs are present in the kidney on glomerular epithelial and vascular endothelial cells.

Purpose of the Study:

To investigate the role of thrombin in inflammatory tissue injury, specifically within the kidney.
To explore the impact of thrombin inhibition on the pathogenesis of crescentic glomerulonephritis.

Main Methods:

Review and discussion of existing literature on thrombin's function and PAR signaling in renal inflammation.
Analysis of the potential therapeutic effects of thrombin inhibition in crescentic glomerulonephritis models.

Related Experiment Videos

Main Results:

Thrombin activation of PARs contributes to the inflammatory processes in kidney injury.
Evidence suggests a significant role for thrombin in the development of crescentic glomerulonephritis.

Conclusions:

Thrombin signaling via PARs is implicated in inflammatory kidney diseases.
Thrombin inhibition presents a potential therapeutic strategy for managing crescentic glomerulonephritis.